Loading...
KMB logo

Kimberly-Clark CorporationNasdaqGS:KMB Voorraadrapport

Marktkapitalisatie US$32.9b
Prijs aandeel
US$99.14
US$114.86
13.7% ondergewaardeerd intrinsieke korting
1Y-30.6%
7D2.8%
1D
Portefeuillewaarde
Bekijk

Kimberly-Clark Corporation

NasdaqGS:KMB Voorraadrapport

Marktkapitalisatie: US$32.9b

Kimberly-Clark (KMB) Aandelenoverzicht

Kimberly-Clark Corporation produceert en verkoopt samen met haar dochterondernemingen producten voor persoonlijke verzorging in de Verenigde Staten. Meer informatie

KMB Community Fair Values

Create Narrative

See what 122 others think this stock is worth. Follow their fair value or set your own to get alerts.

Kimberly-Clark Corporation Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor Kimberly-Clark
Historische aandelenkoersen
Huidige aandelenkoersUS$99.14
52 Week HoogtepuntUS$144.31
52 Week LaagUS$92.42
Bèta0.31
1 maand verandering1.32%
3 maanden verandering-9.22%
1 Jaar Verandering-30.60%
3 jaar verandering-25.78%
5 jaar verandering-23.74%
Verandering sinds IPO5,465.76%

Recent nieuws en updates

Seeking Alpha 2h

Kimberly-Clark: Caught In An Inflationary Squeeze

Summary Based on management guidance, Kimberly-Clark is expected to generate free cash flows of $2.0 billion in 2026, roughly in line with the 5-year average. To highlight the lack of growth in its portfolio, the company also generated free cash flows of $2.0 billion back in 2013. Indeed, 13 years without growth is a long time. In early November 2025, Kimberly-Clark announced the acquisition of the consumer health giant Kenvue at an enterprise value of approximately $48.7 billion. While I view both portfolios as highly complementary, any corporate transaction of this size is not without risks, and that includes the $2.1 billion of expected annual run-rate synergies. Kimberly-Clark seems to be caught in a squeeze, with the inability to raise prices on one hand, combined with rapidly rising input costs on the other. If packaged food companies are any indication of what may happen to KMB's margins, I think there could be more downside from here. Read the full article on Seeking Alpha

Recent updates

Seeking Alpha 2h

Kimberly-Clark: Caught In An Inflationary Squeeze

Summary Based on management guidance, Kimberly-Clark is expected to generate free cash flows of $2.0 billion in 2026, roughly in line with the 5-year average. To highlight the lack of growth in its portfolio, the company also generated free cash flows of $2.0 billion back in 2013. Indeed, 13 years without growth is a long time. In early November 2025, Kimberly-Clark announced the acquisition of the consumer health giant Kenvue at an enterprise value of approximately $48.7 billion. While I view both portfolios as highly complementary, any corporate transaction of this size is not without risks, and that includes the $2.1 billion of expected annual run-rate synergies. Kimberly-Clark seems to be caught in a squeeze, with the inability to raise prices on one hand, combined with rapidly rising input costs on the other. If packaged food companies are any indication of what may happen to KMB's margins, I think there could be more downside from here. Read the full article on Seeking Alpha
Analyseartikel May 05

We Think You Can Look Beyond Kimberly-Clark's (NASDAQ:KMB) Lackluster Earnings

Shareholders appeared unconcerned with Kimberly-Clark Corporation's ( NASDAQ:KMB ) lackluster earnings report last...
Narratiefupdate Apr 25

KMB: Future Returns Will Hinge On Cost Hedges Versus Post 2026 Oil Pressures

Analysts have trimmed the Kimberly-Clark fair value estimate by about $2 to $114.86 as a wave of recent price target cuts. While they still acknowledge stable discount rate assumptions and steady to slightly adjusted expectations for revenue growth, profit margin, and future P/E, this points to more cautious sentiment around the shares.
Narratiefupdate Apr 10

KMB: Future Returns Will Depend On Cost Hedges Holding Off Oil Pressures

Narrative Update Kimberly-Clark's fair value estimate has shifted modestly higher to $116.79 as analysts refresh price targets in light of recent broad sector resets and updated views on hedged input costs and potential longer term oil related risks. Analyst Commentary Recent Street research on Kimberly-Clark centers on refreshed price targets, with most firms adjusting levels while keeping a close eye on execution, cost visibility and input price risk.
Nieuw narratief Apr 08

Kimberly-Clark Corp (KMB): The "Essential Innovator" Scaling a $2 Billion AI-Powered Supply Chain

Kimberly-Clark Corp (KMB) , the global personal care giant, closed the April 8, 2026, session at $97.00 USD on the NASDAQ. The stock posted a strong +4.25% rally today, rebounding sharply as the market recognized its technical support floor near $92.
Narratiefupdate Mar 26

KMB: Future Returns Will Hinge On Cost Hedges Versus 2027 Oil Risk

The analyst price target for Kimberly-Clark has shifted from about $119 to roughly $114, as analysts factor in steady near term top-line trends, cost hedging through 2026, and potential oil related cost risk for 2027. Analyst Commentary Recent research shows a mix of optimism and caution around Kimberly-Clark, with price targets moving in a relatively tight band and different views on how near term execution and cost risk feed into valuation.
Narratiefupdate Mar 12

KMB: Future Returns Will Hinge On Kenvue Merger Outcome

Analysts have adjusted their view on Kimberly-Clark with the latest price targets, including a recent move to $110 from $105. This reflects refreshed expectations across the consumer staples sector.
Narratiefupdate Feb 26

KMB: Future Returns Will Depend On Kenvue Merger And Sector Repricing

Our Kimberly-Clark narrative update reflects a modest $0.50 lift in fair value, as analysts recalibrate price targets such as the recent Wells Fargo move to $110 and other sector wide revisions, while incorporating updated assumptions for revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on Kimberly-Clark has been mixed, with several firms adjusting price targets in both directions as they update sector views, reassess valuation frameworks and reset expectations for the consumer staples group.
Narratiefupdate Feb 11

KMB: Future Upside Will Hinge On Kenvue Merger Execution And Integration

The analyst price target for Kimberly-Clark has shifted by about $3, reflecting a mix of recent target cuts from several firms and a smaller upward revision as analysts reassess growth expectations, profit margin assumptions and the appropriate future P/E multiple. Analyst Commentary Recent research on Kimberly-Clark has been active, with several firms adjusting their price targets and ratings as they rework growth assumptions, margin expectations and the P/E multiple they are comfortable applying to the stock.
Analyseartikel Jan 30

Kimberly-Clark's (NASDAQ:KMB) Upcoming Dividend Will Be Larger Than Last Year's

Kimberly-Clark Corporation's ( NASDAQ:KMB ) periodic dividend will be increasing on the 2nd of April to $1.28, with...
Narratiefupdate Jan 27

KMB: Future Upside Will Depend On Successful Kenvue Acquisition Integration

Our analyst price target for Kimberly-Clark has been trimmed by about US$4.50 per share, as analysts factor in lower implied fair value, a slightly more conservative future P/E multiple, and modest adjustments to profit margin assumptions following a series of recent target cuts across the Street. Analyst Commentary Recent Street research on Kimberly-Clark shows a mix of optimism and caution, with several firms revising price targets following the Kenvue acquisition announcement and broader consumer staples outlook updates.
Narratiefupdate Jan 12

KMB: Future Upside Will Hinge On Executing The Kenvue Acquisition

Analysts have nudged their price expectations for Kimberly-Clark slightly lower, with our fair value estimate moving from US$127.73 to US$126.60 as they balance cautious sector views and deal execution risks with generally supportive opinions on the Kenvue acquisition and recent earnings updates. Analyst Commentary Recent research on Kimberly-Clark reflects a split view, with some analysts focusing on execution risk and muted category trends, while others see support from resilient fundamentals and the Kenvue deal opportunity.
Narratiefupdate Dec 14

KMB: Future Upside Will Depend On Successful Kenvue Acquisition Execution

Analysts have modestly trimmed our Kimberly-Clark fair value estimate by about $1 to roughly $128 per share, reflecting a lower assumed future P E multiple, even as they factor in stronger revenue growth and higher profit margins supported by recent target moves and upgrade activity. Analyst Commentary Recent Street research reflects a mix of optimism about Kimberly-Clark's improved growth and margin profile and caution around execution risks tied to the planned Kenvue acquisition.
Narratiefupdate Nov 29

KMB: Future Returns Will Be Driven By The Kenvue Acquisition Execution

Kimberly-Clark's analyst price target was modestly increased from $128.63 to $128.87, as analysts factor in stable sales performance and balanced risks from recent strategic moves. Analyst Commentary Following recent developments for Kimberly-Clark, analysts have offered a mix of optimism and caution regarding the company's outlook.
Narratiefupdate Nov 15

KMB: Future Upside Will Be Driven By The Kenvue Acquisition

Kimberly-Clark's analyst price target has been revised downward from approximately $137 to $129 per share, as analysts account for increased risk tied to the Kenvue acquisition. Analysts have also noted recent upgrades and changes in the company’s growth outlook.
Narratiefupdate Nov 01

KMB: Future Margin Improvements Will Drive Upside Amid Market Uncertainty

The analyst average price target for Kimberly-Clark has decreased slightly from $138 to approximately $137.22. Analysts cite adjustments to growth expectations in the personal care segment, but also note some recent target increases reflecting updated models.
Narratiefupdate Oct 17

Personal Care And Hygiene Demand Will Yield Enduring Global Opportunity

Kimberly-Clark's analyst price target has been revised downward by $2.71 to $138.00. Analysts cite muted and decelerating growth in certain personal care segments as a key factor for the adjustment.
Narratiefupdate Oct 03

Personal Care And Hygiene Demand Will Yield Enduring Global Opportunity

Kimberly-Clark's average analyst price target has been reduced by $1.36 to $140.71, as analysts point to muted growth prospects in parts of the personal care sector. However, there is ongoing confidence in the company's long-term positioning.
Analyseartikel Aug 07

Kimberly-Clark Corporation (NASDAQ:KMB) Analysts Just Slashed This Year's Revenue Estimates By 12%

NasdaqGS:KMB 1 Year Share Price vs Fair Value Explore Kimberly-Clark's Fair Values from the Community and select yours...
Analyseartikel Aug 04

Kimberly-Clark Corporation Just Missed Earnings - But Analysts Have Updated Their Models

As you might know, Kimberly-Clark Corporation ( NASDAQ:KMB ) last week released its latest quarterly, and things did...
Analyseartikel Jul 22

Kimberly-Clark (NASDAQ:KMB) Has Some Way To Go To Become A Multi-Bagger

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
User avatar
Nieuw narratief Jul 16

Global Consumer Demand Will Create Enduring Market Opportunity

Accelerated product innovation and strategic marketing position the company to capture rising demand and expand market share across consumer segments globally.
Analyseartikel Jul 06

Is Kimberly-Clark (NASDAQ:KMB) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Seeking Alpha Apr 24

Kimberly-Clark: Downgrade Back To Sell Rating On Negative Earnings Outlook

Summary I downgrade Kimberly-Clark stock to a sell due to a structurally weaker pricing environment and growing margin pressures revealed in 1Q25 results. KMB's net sales fell 6% y/y, with broad-based weakness and deliberate price cuts, signaling deteriorating pricing power and increased cost pressures from tariffs. Management's strategic price investments and tariff impacts are expected to hit earnings hard, making the current 18x forward P/E valuation unsustainable. Read the full article on Seeking Alpha
Seeking Alpha Mar 27

Kimberly-Clark: Streamlining Portfolio & Global Footprint; Initiate With 'Buy'

Summary Kimberly-Clark has streamlined its portfolio and footprint, focusing on acquisitions and divestitures to accelerate organic revenue growth, earning a ‘buy’ rating with a fair value of $151 per share. The company’s Integrated Margin Management approach has optimized expenses, expanded margins, and contributed to 3.2% organic revenue growth and 15.6% adjusted operating profit growth in FY24. Despite slow growth historically, strategic acquisitions like Thinx and divestitures like Neve tissue brand in Brazil support future above-market growth and portfolio optimization. Risks include heavy reliance on Walmart, workforce reductions, and FX fluctuations, but effective cost management and portfolio streamlining could create long-term shareholder value. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Kimberly-Clark: Troubles Are Lurking Beneath The Adjusted Numbers

Summary Kimberly-Clark's Q4 2024 and full fiscal year results earlier this week were a non-event for the market. The release, however, raises some red flags for 2025 and beyond with GAAP margins expected to remain under pressure. Returning cash to shareholders seems to be a priority for KMB's management which in my view is a problem for long-term shareholders. Read the full article on Seeking Alpha
Seeking Alpha Dec 27

Kimberly-Clark: Fine Valuation, But Lack Of Growth Limits Upside

Summary Kimberly-Clark Corporation's stable business model and consistent dividend growth have made it a long-time favorite for income-focused investors, despite recent underperformance. The company's growth has stalled due to flat revenues, competition from private labels, and challenges in international markets. Cost-cutting and share repurchases are being used to drive profitability, but organic sales growth remains tepid. KMB stock is a hold for now, as there are other consumer staples stocks with more appealing valuations today. Read the full article on Seeking Alpha
Seeking Alpha Nov 27

Kimberly-Clark: Generously Priced With Margin Pressures Ahead

Summary Kimberly-Clark's strong share price performance in 2024 is likely to come to an end over the coming year. Further margin improvements appear unlikely as pricing tailwinds dissipate. The share price is also running ahead of business fundamentals and this will weigh on shareholder returns over the coming year. Read the full article on Seeking Alpha

Rendement voor aandeelhouders

KMBUS Household ProductsUS Markt
7D2.8%1.4%1.2%
1Y-30.6%-13.5%28.7%

Rendement versus industrie: KMB presteerde slechter dan de US Household Products -sector, die het afgelopen jaar een rendement van -13.5 % opleverde.

Rendement versus markt: KMB presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 28.7 % opleverde.

Prijsvolatiliteit

Is KMB's price volatile compared to industry and market?
KMB volatility
KMB Average Weekly Movement3.4%
Household Products Industry Average Movement3.5%
Market Average Movement7.2%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: KMB heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van KMB is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
187236,000Mike Hsuwww.kimberly-clark.com

Kimberly-Clark Corporation produceert en verkoopt samen met haar dochterondernemingen persoonlijke verzorgingsproducten in de Verenigde Staten. Het bedrijf is actief in twee segmenten, Noord-Amerika en Internationale Persoonlijke Verzorging. Het Noord-Amerikaanse segment biedt wegwerpluiers, oefen- en jeugdbroeken, zwembroeken, babydoekjes, dames- en incontinentieverzorgingsproducten, herbruikbaar ondergoed, gezichts- en toiletpapier, papieren handdoeken, servetten, wissers, tissues, handdoeken, zeep en ontsmettingsmiddelen en andere gerelateerde producten onder de merknamen Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall en andere.

Kimberly-Clark Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Kimberly-Clark zich tot de beurswaarde?
KMB fundamentele statistieken
MarktkapitalisatieUS$32.91b
Inkomsten(TTM)US$1.72b
Inkomsten(TTM)US$16.56b
19.1x
Koers/Winstverhouding
2.0x
P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
KMB resultatenrekening (TTM)
InkomstenUS$16.56b
Kosten van inkomstenUS$10.41b
BrutowinstUS$6.15b
Overige uitgavenUS$4.43b
InkomstenUS$1.72b

Laatst gerapporteerde inkomsten

Mar 31, 2026

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)5.18
Brutomarge37.15%
Nettowinstmarge10.40%
Schuld/Eigen Vermogen Verhouding371.3%

Hoe presteerde KMB op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

5.2%
Huidig dividendrendement
98%
Uitbetalingsratio

Betaalt KMB een betrouwbaar dividend?

Zie KMB dividendgeschiedenis en benchmarks
Wanneer moet je KMB kopen om een aanstaand dividend te ontvangen?
Kimberly-Clark dividenddata
Ex Dividend DatumJun 05 2026
Betaaldatum dividendJul 02 2026
Dagen tot Ex-dividend9 days
Dagen tot dividendbetaaldatum36 days

Betaalt KMB een betrouwbaar dividend?

Zie KMB dividendgeschiedenis en benchmarks

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/26 14:17
Aandelenkoers aan het einde van de dag2026/05/22 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Kimberly-Clark Corporation wordt gevolgd door 34 analisten. 15 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
John StaszakArgus Research Company
Lauren LiebermanBarclays
Lauren LiebermanBarclays